Company Filing History:
Years Active: 2011
Title: Innovations of Michael McLane
Introduction
Michael McLane is an accomplished inventor based in Plymouth Meeting, PA. He holds two patents that showcase his contributions to the field of pharmaceuticals. His work primarily focuses on innovative methods and compounds that have significant therapeutic applications.
Latest Patents
One of McLane's latest patents is titled "Polymorphic and amorphous salt forms of squalamine dilactate." This invention relates to select squalamine salts, methods of their synthesis, and their therapeutic use. It highlights the advantages of these salts concerning manufacturing, product stability, and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation. Another notable patent is "Methods for the modulation of IL-13." This invention focuses on methods for modulating IL-13 expression and/or activity in a mammal by administering an effective amount of an agent that modulates the expression and/or activity of IL-9.
Career Highlights
Throughout his career, McLane has worked with several prominent companies, including Ohr Pharmaceuticals, Inc. and Ligand Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and has enabled him to develop innovative solutions to complex medical challenges.
Collaborations
Some of McLane's notable coworkers include Roy Clifford Levitt and Eric Chellquist. Their collaboration has likely fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.
Conclusion
Michael McLane's contributions to the field of pharmaceuticals through his patents demonstrate his commitment to innovation and improving therapeutic methods. His work continues to impact the industry positively.